Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
US claims data characterize SMA resource use; leaves open targeted interventions pending prospective validation.
Describe HRU among patients with diagnostic codes for SMA in a US commercial claims database.
No takes yet. Share an insight, caveat, or question.
Teynor et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: